Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrrolate manufacturers

Filters

None products found

glycopyrrolate

Oral solution 1 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Status: SSPL has successfully developed & established following formulations of glycopyrrolate against RLD Cuvposa. We are in process taking validation batches at our EU-GMP site and soon will be ready with an e-CTD dossier for out-licensing.
Manufacturer #7738
A pharmaceutical manufacturer specialised in both active pharmaceutical ingredients (APIs) and finished dosage pharmaceutical products, with capabilities spanning complex technologies (such as polysaccharides) and advanced intermediate manufacturing. The company’s facilities are certified by major regulatory authorities including US FDA inspection, EU-GMP certification, WHO-GMP certification, plus approvals from COFEPRIS (Mexico) and the Korean MFDS, supporting global supply to multiple regions worldwide.

Manufacturer usually replies in 7 days

glycopyrrolate

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Status: SSPL has successfully developed & established following formulations of glycopyrrolate against RLD Cuvposa. We are in process taking validation batches at our EU-GMP site and soon will be ready with an e-CTD dossier for out-licensing.
Manufacturer #7738
A pharmaceutical manufacturer specialised in both active pharmaceutical ingredients (APIs) and finished dosage pharmaceutical products, with capabilities spanning complex technologies (such as polysaccharides) and advanced intermediate manufacturing. The company’s facilities are certified by major regulatory authorities including US FDA inspection, EU-GMP certification, WHO-GMP certification, plus approvals from COFEPRIS (Mexico) and the Korean MFDS, supporting global supply to multiple regions worldwide.

Manufacturer usually replies in 7 days

glycopyrrolate

Tablets 1 mg, 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Manufacturer #12311
This pharmaceutical company specializes in developing and supplying drug products and substances to global markets. Their focus is on innovation and quality, offering both prescription and over-the-counter products. The company boasts strong GMP certifications, ensuring adherence to international standards. Their portfolio likely includes solid dosage forms and may extend to injectables or liquids. While specific therapy areas are not mentioned, the focus on advanced markets suggests specialization in areas like oncology, cardiology, or neurology. With a proven track record of supplying high-quality pharmaceuticals, they likely hold multiple product patents. The company's decades-long presence in the industry, particularly in the European Union and North America, underscores their commitment to global healthcare solutions.

Manufacturer usually replies in 13 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.